Menactra
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN · Injection, Solution · Intramuscular
No FDA structured label text is available for Menactra. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen in 1 product
- Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen in 1 product
- Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen in 1 product
- Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen in 1 product
Menactra NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 49281-589 | Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen 4 ug/.5mL; Neisseria… Injection, Solution | Sanofi Vaccines US Inc. | BLA |
Frequently asked questions
Who makes Menactra?
Menactra is listed by 1 labeler in the FDA NDC directory, including Sanofi Vaccines US Inc..